                               SEQUENCE LISTING

<110> REGENERON PHARMACEUTICALS, INC.
 
<120> A HIGH-THROUGHPUT AND MASS-SPECTROMETRY-BASED METHOD FOR 
      QUANTITATING ANTIBODIES

<130> 064752.032PCT1

<140>
<141>

<150> 63/036,679
<151> 2020-06-09

<160> 1     

<170> PatentIn version 3.5

<210> 1
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1
Val Val Ser Val Leu Thr Val Leu His Gln Asp Trp Leu Asn Gly Lys 
1               5                   10                  15      




